Legend Biotech (LEGN) EBIAT: 2019-2025
Historic EBIAT for Legend Biotech (LEGN) over the last 7 years, with Sep 2025 value amounting to -$39.7 million.
- Legend Biotech's EBIAT rose 68.33% to -$39.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$266.0 million, marking a year-over-year decrease of 30.72%. This contributed to the annual value of -$177.0 million for FY2024, which is 65.84% up from last year.
- Latest data reveals that Legend Biotech reported EBIAT of -$39.7 million as of Q3 2025, which was up 68.35% from -$125.4 million recorded in Q2 2025.
- In the past 5 years, Legend Biotech's EBIAT ranged from a high of $26,284 in Q4 2024 and a low of -$199.1 million during Q2 2023.
- Moreover, its 3-year median value for EBIAT was -$62.2 million (2023), whereas its average is -$76.6 million.
- As far as peak fluctuations go, Legend Biotech's EBIAT crashed by 35,570.18% in 2022, and later soared by 118.15% in 2024.
- Legend Biotech's EBIAT (Quarterly) stood at -$88.3 million in 2021, then tumbled by 53.82% to -$135.9 million in 2022, then surged by 99.89% to -$144,818 in 2023, then skyrocketed by 118.15% to $26,284 in 2024, then surged by 68.33% to -$39.7 million in 2025.
- Its EBIAT was -$39.7 million in Q3 2025, compared to -$125.4 million in Q2 2025 and -$100.9 million in Q1 2025.